This selection from the NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC)
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell
Lung Cancer (NSCLC) provide recommended management for patients with NSCLC …

The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of
management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the …

These NCCN Guidelines Insights focus on recent updates in the 2016 NCCN Guidelines for
Non–Small Cell Lung Cancer (NSCLC; Versions 1–4). These NCCN Guidelines Insights will …

The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of
management for NSCLC. These NCCN Guidelines Insights focus on recent updates in …

These NCCN Guidelines Insights focus on the diagnostic evaluation of suspected lung
cancer. This topic was the subject of a major update in the 2013 NCCN Clinical Practice …

Lung cancer is the leading cause of cancer death in the United States in both men and
women. An estimated 226,160 new cases will be diagnosed in 2012, and 160,340 deaths …

For the use of immunotherapy in metastatic non–small cell lung cancer (NSCLC), the NCCN
Guidelines for NSCLC reflect the importance of assessing levels of PD-L1 expression to …

The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations
for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus …

Living guidelines are developed for selected topic areas with rapidly evolving evidence that
drives frequent change in recommended clinical practice. Living guidelines are updated on …